Eli Lilly and Company (LLY) Stock Analysis — Probabli.AI
AI-powered analysis for LLY (Eli Lilly and Company): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
← Healthcare Stocks
Last price: $895.17 · Market cap: $829.7B · AI consensus: Bullish
Eli Lilly demonstrates strong fundamentals, underscored by consistent earnings beats, a robust pipeline, and strategic market expansions. While recognizing potential risks, these strengths position it well for above-average growth.
Probabilistic 1-Year Outlook
- Bull 5500% · Neutral 3000% · Bear 1500%
- Eli Lilly is strategically positioned with a robust pipeline and expanding markets, complemented by strong fundamentals, as evidenced by recent earnings growth and consistent outperformance against estimates.
5-Year Outlook
- Bull 6000% · Neutral 2500% · Bear 1500%
SWOT Highlights
- Strength: Innovative drug pipeline.
- Strength: Consistently beats EPS estimates.
- Risk: Low dividend yield.
- Risk: High dependence on specific products.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
19 Wall Street analysts rate LLY a BUY with a mean price target of $1,217.79. Eli Lilly and Company currently pays a dividend with a yield of approximately 0.77%.
Analysis generated Apr 21, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/LLY.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.